RCAN1 is a negative regulator of calcineurin-dependent transcriptional responses, functioning primarily through direct binding to the catalytic domain of calcineurin A 1. The protein operates as a calcium-dependent signaling regulator and is localized to both cytoplasm and nucleus, where it inhibits the calcineurin-NFAT signaling cascade 2. Mechanistically, RCAN1 regulates mitochondrial function through the JNK/Mff signaling pathway, promoting dynamin-related protein 1 (Drp1) phosphorylation and mitochondrial fission 3. Acute RCAN1 induction during cellular stress (hours to days) appears protective by suppressing pro-apoptotic genes, whereas chr21 overexpression causes detrimental mitochondrial dysfunction and cellular damage 2. Disease relevance is substantial. RCAN1 is overexpressed on chromosome 21 and implicated in Down syndrome pathology, with elevated levels linked to enamel formation defects through increased reactive oxygen species and impaired mitochondrial bioenergetics 4. In diabetic cardiomyopathy, RCAN1 upregulation associates with lipid accumulation and mitochondrial fission, promoting heart failure progression 5. RCAN1 also contributes to Alzheimer's disease pathophysiology and type 2 diabetes via neuronal and endocrine dysfunction 2. In acute kidney injury, RCAN1 deletion protects against mitochondrial dysfunction and apoptosis 3. The protein additionally functions as a transcriptional target in cardiac hypertrophy through ETS2-NFAT cooperation 6.